Ionis Pharmaceuticals Inc
IONS· Nasdaq
Ionis Pharmaceuticals Inc
- Last sale
- Oct 2, 2026 · -0.94%
- Market cap
- $7.24B
- 166.18M shares
- Filings
- 1,073
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $943,711,000 | reported | |
| FY 2024 | 2024-12-31 | $705,138,000 | reported | |
| FY 2023 | 2023-12-31 | $787,647,000 | reported | |
| FY 2022 | 2022-12-31 | $587,367,000 | reported | |
| FY 2021 | 2021-12-31 | $810,456,000 | reported | |
| FY 2020 | 2020-12-31 | $729,264,000 | reported | |
| FY 2019 | 2019-12-31 | $1,122,599,000 | reported | |
| FY 2018 | 2018-12-31 | $599,674,000 | reported | |
| FY 2017 | 2017-12-31 | $514,179,000 revised | reported | |
| FY 2016 | 2016-12-31 | $372,776,000 revised | reported | |
| FY 2015 | 2015-12-31 | $283,703,000 | reported | |
| FY 2014 | 2014-12-31 | $214,161,000 | reported |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
